Buclizine Hydrochloride

盐酸布克力嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBuclizine Hydrochloride
Drug Alias Name盐酸布可立嗪buclizine布克力嗪buclizinumbuclizina +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsNauseaHypersensitivityPruritus +[5
Global Approved IndicationsNauseaHypersensitivityPruritus +[5
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/04/08
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAkzo Nobel
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStuart Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsNauseaHypersensitivityPruritus +[5

Other Information

ATC CodeR06AE01